Publicaciones en las que colabora con SAMUEL NAVARRO FOS (11)

2019

  1. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2017

  1. Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases

    Medicina Clinica, Vol. 149, Núm. 4, pp. 153-156

2012

  1. Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: What is the impact on lymph node harvest after colon resection for cancer?

    Diseases of the Colon and Rectum, Vol. 55, Núm. 2, pp. 197-204

2011

  1. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer

    Cancer, Vol. 117, Núm. 14, pp. 3118-3125

2010

  1. The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment

    Clinical and Translational Oncology, Vol. 12, Núm. 5, pp. 339-345

2009

  1. Macroscopic assessment of mesorectal excision in rectal cancer: A useful tool for improving quality control in a multidisciplinary team

    Cancer, Vol. 115, Núm. 15, pp. 3400-3411

  2. Prognostic heterogeneity of endosonographic T3 rectal cancer

    Diseases of the Colon and Rectum, Vol. 52, Núm. 4, pp. 685-691

2008

  1. Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: Perioperative management of rectal cancer

    Annals of Oncology

2007

  1. Integrative decisions in rectal cancer

    Annals of Oncology

2006

  1. A multimodality approach to localized rectal cancer

    Annals of Oncology, Vol. 17, Núm. SUPPL. 10